Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment-Reference-Cited by-同舟云学术

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment

Published:2019-05-29 Issue:5 Volume:14 Page:e0217208
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bedri Sahl Khalid^ORCID,Nilsson Ola B.,Fink Katharina,Månberg Anna,Hamsten Carl,Ayoglu Burcu,Manouchehrinia Ali,Nilsson Peter,Olsson Tomas,Hillert Jan,Grönlund Hans,Glaser Anna

Funder

Genzyme

Vetenskapsrådet

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Multiple sclerosis;A Compston;Lancet,2002

2. WHO. Atlas multiple sclerosis resources in the world 2008. 2008. Available from: https://www.who.int/mental_health/neurology/Atlas_MS_WEB.pdf.

3. Multiple Sclerosis;BI Yamout;Semin Neurol,2018

4. Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis;L Prosperini;J Neurol,2017

5. Protein microarray technology;MF Templin;Trends Biotechnol,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomics and Management of Multiple Sclerosis;Pharmacoproteomics;2024

2. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor;World Journal of Gastroenterology;2023-07-14

3. Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis;Frontiers in Genetics;2023-01-30

4. Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools;Cancers;2022-10-17

5. Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis;Journal of Clinical Medicine;2022-07-15